The changes of visfatin in serum and its expression in fat and placental tissue in pregnant women with gestational diabetes

Diabetes Research and Clinical Practice

Volumn 90, Issue 1, 2010, Pages 60-65

  Ma, Yao ^a   Cheng, Yan ^a   Wang, Jue ^a   Cheng, Haidong ^a   Zhou, Shufeng ^b   Li, Xiaotian ^a  

^a FUDAN UNIVERSITY   (China)

^b RMIT UNIVERSITY   (Australia)

Author keywords

Adipose tissue; BeWo cells; Gestational diabetes mellitus; Placenta; Visfatin

Indexed keywords

GLUCOSE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETOGENESIS; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; PLACENTA; PREGNANCY DIABETES MELLITUS; PRENATAL PERIOD; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PUERPERIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING;

ADIPOSE TISSUE, WHITE; ADULT; CELL LINE; CYTOKINES; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OSMOLAR CONCENTRATION; PERIPARTUM PERIOD; PLACENTA; POSTPARTUM PERIOD; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBCUTANEOUS FAT; TERM BIRTH; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956191102     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.06.010     Document Type: Article

References (23)

1. Ryan E.A., Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab 1988, 67:341-347.
2. Briana D.D., Malamitsi-Puchner A. Reviews: adipocytokines in normal and complicated pregnancies. Reprod Sci 2009, 16:921-937.
3. Desoye G., Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007, 30(Suppl. 2):S120-S126.
4. Chen J., Tan B., Karteris E., Zervou S., Digby J., Hillhouse E.W., et al. Secretion of adiponectin by human placenta: differential modulation of adiponectin and its receptors by cytokines. Diabetologia 2006, 49:1292-1302.
5. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994, 14:1431-1437.
6. Preiss J., Handler P. Enzymatic synthesis of nicotinamide mononucleotide. J Biol Chem 1957, 225:759-770.
7. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
8. Revollo J.R., Grimm A.A., Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr Opin Gastroenterol 2007, 23:164-170.
9. Filippatos T.D., Derdemezis C.S., Gazi I.F., Lagos K., Kiortsis D.N., Tselepis A.D., et al. Increased plasma visfatin levels in subjects with the metabolic syndrome. Eur J Clin Invest 2008, 38:71-72.
10. Jia S.H., Li Y., Parodo J., Kapus A., Fan L., Rotstein O.D., et al. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004, 113:1318-1327.
11. Morgan S.A., Bringolf J.B., Seidel E.R. Visfatin expression is elevated in normal human pregnancy. Peptides 2008, 29:1382-1389.
12. Ognjanovic S., Bryant-Greenwood G.D. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002, 187:1051-1058.
13. Kirwan J.P., Hauguel-De Mouzon S., Lepercq J., Challier J.C., Huston-Presley L., Friedman J.E., et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002, 51:2207-2213.
14. Gestational diabetes mellitus. Diabetes Care 2004, 27(Suppl. 1):S88-S90.
15. Patel N., Alsat E., Igout A., Baron F., Hennen G., Porquet D., et al. Glucose inhibits human placental GH secretion, in vitro. J Clin Endocrinol Metab 1995, 80:1743-1746.
16. Lewandowski K.C., Stojanovic N., Press M., Tuck S.M., Szosland K., Bienkiewicz M., et al. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance. Diabetologia 2007, 50:1033-1037.
17. Krzyzanowska K., Krugluger W., Mittermayer F., Rahman R., Haider D., Shnawa N., et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006, 110:605-609.
18. Telejko B., Kuzmicki M., Zonenberg A., Szamatowicz J., Wawrusiewicz-Kurylonek N., Nikolajuk A., et al. Visfatin in gestational diabetes: serum level and mRNA expression in fat and placental tissue. Diabetes Res Clin Pract 2009, 84:68-75.
19. Revollo J.R., Korner A., Mills K.F., Satoh A., Wang T., Garten A., et al. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007, 6:363-375.
20. Song H.K., Lee M.H., Kim B.K., Park Y.G., Ko G.J., Kang Y.S., et al. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am J Physiol Renal Physiol 2008, 295:F1485-F1494.
21. Ognjanovic S., Bao S., Yamamoto S.Y., Garibay-Tupas J., Samal B., Bryant-Greenwood G.D. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 2001, 26:107-117.
22. Haider S., Knofler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 2009, 30:111-123.
23. Chen H.L., Yang Y.P., Hu X.L., Yelavarthi K.K., Fishback J.L., Hunt J.S. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991, 139:327-335.